Diabetic

New York, Oct. 19, 2023 (GLOBE NEWSWIRE) -- In 2022, global revenue for Diabetic Nephropathy reached approximately $2.37 billion, projected to grow at a 6.70% CAGR, hitting $4.86 billion by 2033. It holds a 2.0% revenue share in the…

89% and 84% of patients were maintained on ≥12- and ≥16-week dosing intervals, respectively, throughout the two-year period, while sustaining their vision and anatomic improvements At two years, 44% of patients met the criteria for…

Diabetic eye diseases are the leading cause of blindness in the working age populationVX-01 is an oral therapy – current treatments require regular invasive intravitreal injections and intervene at advanced stages of diseaseSet to commence…

Wilmington, Delaware, United States, July 24, 2023 (GLOBE NEWSWIRE) -- The global diabetic foot ulcer treatment market stood at US$ 7.0 Bn in 2022. It is projected to expand at a CAGR of 5.8% from 2023 to 2031. Increase in incidence of…

89% of all aflibercept 8 mg patients maintained ≥12-week dosing intervals through two years Of those assigned to a 16-week dosing regimen at baseline, 83% maintained ≥16-week dosing intervals through two years Many patients met the…

Lori Solomon MONDAY, June 12, 2023 (HealthDay News) -- Artificial intelligence (AI)-determined best-corrected visual acuity (BCVA) from remotely obtained fundus photographs is feasible for…

Elana Gotkine WEDNESDAY, May 31, 2023 (HealthDay News) -- For patients with diabetes, an automated binary diabetic macular ischemia (DMI) algorithm using optical coherence tomography…

Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal…

<!-- Name:DistributionId Value:8843293 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4570 -->…

<!-- Name:DistributionId Value:8832991 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…